Form 6-K ONCOLYTICS BIOTECH INC For: Feb 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
BeiGene Ltd. (ONC) PT Raised to $308 at Jefferies
February 27, 2025 3:36 PM ESTJefferies analyst Kelly Shi raised the price target on BeiGene Ltd. (NASDAQ: ONC) to $308.00 (from $286.00) while maintaining a Buy rating.
The analyst comments "ONC posted strong FY results, with $3.8B FY rev (+55% YoY, vs $3.7B cons). Despite investor discussion of script discrepancies, Brukinsa... More
